Receive our newsletter – data, insights and analysis delivered to you
In association with GlobalData
  1. Research Reports
November 28, 2019

The Crohn’s disease market will continue to rise, dominated by the US, says GlobalData

By GlobalData

Crohn’s disease is an inflammatory bowel condition that comprises two chronic autoimmune diseases. Both Crohn’s disease and ulcerative colitis cause intestinal inflammation and may affect any part of the gastrointestinal tract.

Crohn’s disease is most commonly found to affect the lower portion of the small intestine, as well as the large intestine. The complex disease is characterized by recurring flare-ups that evolve over time with the use of therapy and treatment.


The US will dominate sales in the Crohn’s Disease market

In the report PharmaPoint: Crohn’s Disease – Global Drug Forecast and Market Analysis to 2026, GlobalData explores the sales landscape for CD treatments across the 7MM, estimating that sales for chronic obstructive pulmonary diseases were $9.2bn in 2016.

Over the 10-year forecast period to 2026, the report estimates that the CD market will record a CAGR of 3.8% across the 7MM; in particular, the CAGR will be 4.9% in the US, 1.3% in the five EU countries, and 3.6% in Japan.

The US will dominate the CD market, with an 87.2% share. This is primarily a result of the high costs of pharmaceuticals and the volume of diagnosed prevalent cases of Crohn’s disease.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide


Key highlights of this report include:

  •     An overview of CD epidemiology, etiology, pathophysiology, diagnosis, and management strategies
  •     Market revenue between 2016 and 2026, including annual cost of therapy and major pipeline sales
  •     Pipeline analysis including data for different phases of development, including emerging trends, synopses of innovative projects, and analysis of late-stage products
  •     An insight into the impact of Crohn’s disease on real people, as well as a review of the key market drivers influencing the sector


This report provides a greater understanding of the impact of Crohn’s disease, and how to address unmet market needs. It enables the development of in-licensing and out-licensing strategies through a review of pipeline products, and the formulation of effective marketing and sales strategies by understanding the competitive landscape.


To find out more about this report, visit the GlobalData Report Store


NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy